Medicine focus

  1. Your complete guide to Lumakras (sotorasib) and how to get it

    If you or someone close to you are suffering from non-small cell lung cancer, Lumakras can provide some much-needed hope. Especially in cases where first-line treatments such as chemotherapy or immunotherapy have proven inefficient.

    Here, you'll find all you need to know about this promising second-line treatment inhibitor of the KRAS G12-Mutant NSCLC.

    What is NSCLC?

    There are two forms of lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Observed under a microscope, NSCLC's cancer cells are larger than those of SCLC. That’s how it got its name.

    NSCLC is the most common kind of lung cancer, affecting over 230,000 people each year, in the USA alone. NSCLC tends to progress more slowly than other lung cancers. Around 40% of patients are diagnosed after the cancer has spread to other body parts[2].

    What is Lumakras?

    Lumakras (sotorasib) is a

    Read more »
  2. What we know about Paxlovid (nirmatrelvir and ritonavir): oral antiviral against COVID-19 | New COVID-19 Medicine

    Paxlovid is an antiviral administered orally to patients who are ill with COVID-19 or have been exposed to the coronavirus SARS-CoV-2 and are at risk of developing severe illness. The manufacturer, pharmaceutical and biotechnology giant Pfizer, developed it to patients avoid severe illness which can lead to hospitalization and death. It is meant to be administered at the first sign of infection.

    Read more »
  3. All about Lagevrio (molnupiravir): the first oral antiviral against COVID-19 | New COVID-19 Medicine

    Molnupiravir is an orally administered antiviral medication that inhibits the replication of certain RNA viruses, and is used to treat COVID-19.

    Read more »
  4. Everything patients need to know about Aduhelm (aducanumab) | New Alzheimer's Medicine

    Aduhelm (aducanumab) is a monthly intravenous infusion intended to slow cognitive decline by reducing amyloid beta plaques in the brain.

    Read more »
  5. What is Ubrelvy? | Information & FAQ

    Ubrelvy (ubrogepant) is a calcitonin gene-related peptide (CGRP) receptor antagonist indicated for the acute treatment of migraine headaches with or without aura.

    Read more »
  6. What is Tukysa? | Information & FAQ

    Tukysa (tucatinib) is a medication used in combination with trastuzumab and capecitabine for the treatment of adult patients with advanced, unresectable or metastatic HER2-positive breast cancer.

    Read more »
  7. What is Radicut/Radicava? | Information & FAQ|

    Radicut (edaravone) and Radicava (edaravone) is a medication for the treatment of patients with amyotrophic lateral sclerosis (ALS) and acute ischaemic stroke.

    Read more »
  8. What is Trodelvy? | Information & FAQ

    Trodelvy (sacituzumab govitecan-hziy) is an immune targeted therapy used for the 3rd line treatment of patients with metastatic triple-negative breast cancer (mTNBC).

    Read more »
  9. What is Tagrisso? | Information & FAQ

    Tagrisso (osimertinib) is a kinase inhibitor (targeted therapy) medication.

    Read more »
  10. What is Vyndaqel? | Information & FAQ|

    Vyndaqel (tafamidis) is a medicine indicated for the treatment of transthyretin amyloidosis in patients with stage 1 symptomatic polyneuropathy to delay peripheral neurologic impairment.

    Read more »
  11. What is Tibsovo? | Information & FAQ

    Tibsovo (ivosidenib) is an IDH1 inhibitor (targeted therapy) medication.

    Read more »
  12. What is Enhertu? | Information & FAQ

    Enhertu (fam-trastuzumab deruxtecan-nxki) is an antibody-drug conjugate targeted therapy.

    Read more »
  13. What is Aimovig? | Information & Faq

    Aimovig (erenumab) is a preventive migraine treatment that works by blocking the activity of calcitonin gene-related peptide, a molecule that is involved in migraine attacks

    Read more »
  14. What is Tudca? | Information & Faq

    5 common questions about the supplement that may be useful for ALS, Parkinson's and Alzheimers.

    Read more »
US 0